Steve Boudewijns

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas et al. · Cancer Immunology Immunotherapy · 2020 · 64 citations · Full text

Medicine, Immunology, Oncology +17

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Kalijn F. Bol, Thomas van den Bosch, Gerty Schreibelt et al. · Ophthalmology · 2016 · 48 citations · Full text

Medicine, Immunology, Oncology +14

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Steve Boudewijns, Harm Westdorp, Rutger H.T. Koornstra et al. · Journal of Immunotherapy · 2016 · 33 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

Steve Boudewijns, Martine Bloemendal, Winald R. Gerritsen et al. · Human Vaccines & Immunotherapeutics · 2016 · 26 citations · Full text

Medicine, Immunology, Oncology +17

Immunological responses to adjuvant vaccination with combined CD1c ⁺ myeloid and plasmacytoid dendritic cells in stage III melanoma patients

Martine Bloemendal, Kalijn F. Bol, Steve Boudewijns et al. · OncoImmunology · 2021 · 26 citations · Full text

Medicine, Immunology, Oncology +17